Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to determine the strategy for mass drug administration (MDA) which provides the greatest reductions in prevalence and intensity of Schistosoma mansoni in school-aged children after 4 years of intervention.


Clinical Trial Description

Intestinal schistosomiasis is caused by the blood-dwelling flatworm Schistosoma mansoni. Despite the increasing focus on the use of praziquantel against schistosomiasis infections for the last three decades many areas in Sub-Saharan Africa still have high prevalences and intensities of schistosomiasis especially among school-age children. This is true for the area of Mwanza Region of Tanzania adjacent to Lake Victoria. The study is a six arm study and includes 150 communities (25 in each arm). From each community 100 school children (aged 9-12 years), 100 first year students (aged 7-8 years) and 50 adults (aged 20-55 years) are included, diagnosed and treated with praziquantel using strategies composing of a mixture of community wide treatment (CWT), school-based treatment (SBT) and years without treatment (-T). The 100 school children provided stool specimens on three consecutive days, while the 100 first year students and 50 adults with few exceptions only provided one specimen. The treatment strategies during the 4 years for the different arms are as follows: Arm 1: CWT, CWT, CWT, CWT; Arm 2: CWT, CWT, SBT, SBT; Arm 3: CWT, CWT -T, -T; Arm 4: SBT, SBT, SBT, SBT; Arm 5: SBT, SBT, -T, -T; Arm 6: SBT, -T, SBT, -T. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02162875
Study type Interventional
Source DBL -Institute for Health Research and Development
Contact
Status Completed
Phase N/A
Start date March 2011
Completion date January 2017

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05999825 - Sm-p80 Schistosomiasis Challenge Study Phase 2
Active, not recruiting NCT03910972 - Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults Phase 1/Phase 2
Completed NCT05085470 - Repeated Controlled Human Schistosoma Mansoni Infection N/A
Completed NCT02755324 - Single-sex Controlled Human Schistosomiasis Infection: Safety and Dose Finding N/A
Completed NCT01054651 - A Randomised Trial of Artesunate-sulfamethoxypyrazine/Pyrimethamine Versus Praziquantel for the Treatment of S. Mansoni Phase 3
Completed NCT03893097 - Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children Phase 3
Completed NCT04679831 - Clinical Evaluation of Ujiplus® Against Schistosoma Mansoni Phase 2/Phase 3
Withdrawn NCT02810613 - Leiden University Medical Center Mini Donor Bank N/A
Recruiting NCT06311344 - Filling Key Research Gaps With Clinical Implications in Mansonellosis and Schistosomiasis: a Network Approach N/A